Topics

"Arete Pharmacy Network∨derfield=date∨derval=DESC" News Stories

11:58 EDT 22nd July 2019 | BioPortfolio

Here are the most relevant search results for "Arete Pharmacy Network∨derfield=date∨derval=DESC" found in our extensive news archives from over 250 global news sources.

More Information about Arete Pharmacy Network∨derfield=date∨derval=DESC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Arete Pharmacy Network∨derfield=date∨derval=DESC for you to read. Along with our medical data and news we also list Arete Pharmacy Network∨derfield=date∨derval=DESC Clinical Trials, which are updated daily. BioPortfolio also has a large database of Arete Pharmacy Network∨derfield=date∨derval=DESC Companies for you to search.

Showing "Arete Pharmacy Network derfield date derval DESC" News Articles 1–25 of 10,000+

Monday 22nd July 2019

Community pharmacy contract funding frozen at £2.59bn for next five years

Community pharmacies are set to receive £13bn over the next five years under the latest national contract, with a planned spend of £2.59bn each year.


New/Sealed Agilent PM Startup Kit for Pump P/N: G1311-68710

$175.00 (0 Bids)End Date: Monday Jul-22-2019 13:05:22 PDTBuy It Now for only: $250.00Buy It Now | Bid now | Add to watch list Biotech365 : New/Sealed Agilent PM Startup Kit for Pump P/N: G1311-68710 BioMarketplace You want to propose your … Continue reading →

Agilent / Keysight E4412A 10MHz – 18GHz, -70dBm to +20dBm, GOOD

$600.00End Date: Wednesday Aug-21-2019 10:15:34 PDTBuy It Now for only: $600.00Buy It Now | Add to watch list Biotech365 : Agilent / Keysight E4412A 10MHz – 18GHz, -70dBm to +20dBm, GOOD BioMarketplace You want to propose your products or a … Continue reading →


Agilent HP 8481A Power Sensor, NSN 6625-00-354-9762, Z540 CAL and warranty

$475.00End Date: Monday Jul-22-2019 15:24:38 PDTBuy It Now for only: $475.00Buy It Now | Add to watch list Biotech365 : Agilent HP 8481A Power Sensor, NSN 6625-00-354-9762, Z540 CAL and warranty BioMarketplace You want to propose your products or a … Continue reading →

A new kind of CAR-T becomes a micro-pharmacy, eliminating glioblastoma in mice

In immunotherapy for cancer, the buzziest research is in combinations. The latest brainstorm is an acronym lover’s dream team: CAR-Ts and BiTEs.

DQ® Blizzard® Treat Sales Help Kids on Miracle Treat Day

The brand’s 14th annual fundraising event for Children’s Miracle Network Hospitals® International Dairy Queen Inc.: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005438/en/The 14th Annual DQ

Publix Pharmacy and Beaufort Memorial Hospital Collaborate to Improve Patient Care

Publix Pharmacy and Beaufort Memorial Hospital (BMH) have announced a collaboration to expand health care services for residents of Beaufort County, South Carolina. The agreement includes in-hospital delivery of patient prescriptions from a nearby Publix, as well as in-store telehealth centers at two Publix locations. “Patients are looking for more convenient access to health care, whether it...

Walgreens Find Care™ Platform Introduces Chronic Care Management for Patients with Diabetes, Asthma and COPD

One year since launch, several new partners and health care offerings have been added to Walgreens Find Care Walgreens today announced that it has expanded the Walgreens Find Care™ platform to now include chronic care management, featuring connected devices and digital therapeutic solutions for patients with diabetes, asthma and chronic obstructive pulmonary disease (COPD). In addition, one y...

D2 Consulting Acquires WorkUp, Unique Patient Engagement Company, Enhances Client Operational Efficiencies in Care of Complex Specialty Patients

D2 Consulting, a leading life sciences consulting firm offering strategic and tactical commercialization services to pharmaceutical, biotechnology, medical device and digital health manufacturers, announces its acquisition of

Human medicines European public assessment report (EPAR): Trecondi, treosulfan, Hematopoietic Stem Cell Transplantation, Date of authorisation: 20/06/2019, Status: Authorised

Human medicines European public assessment report (EPAR): Trecondi, treosulfan, Hematopoietic Stem Cell Transplantation, Date of authorisation: 20/06/2019, Status: Authorised

Baxter Announces U.S. FDA Approval of Myxredlin, The First and Only Ready-To-Use Insulin for IV Infusion

Offers extended shelf life of 30 days at room temperature or 24 months refrigerated Novel, ready-to-use presentation eliminates need for admixing and batching Available in standardized concentration Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval of Myxredlin (Insulin H...

Humana and Veterans of Foreign Wars (VFW) Target Health and Well-being of Veterans and Food Insecurity at the 120th VFW National Convention

‘Uniting to Combat Hunger’ Campaign will Triple Goal and Donate More Than 300,000 Meals and 2,000 Cases of Water to Address Food Insecurity among Orlando Residents and Veterans Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, is furthering its commitment to provide veterans with the resources, information and holistic guidance they need to achieve their...

Manhattan Scientifics Updates its Previous July 19th Press Release

Breakthrough Device for Detection of Cancer Manhattan Scientifics (OTC: QB MHTX) clarifies that it continues to own 64 million shares of Imagion Biosystems Ltd (ASX: IBX). Neither MHTX nor its management have sold any MHTX or IBX shares and have no present intention to do so. This clarification is published as a result of recent unusually large t

There’s Lots Of Talk About Surprise Medical Bills In Congress, But Ambulance Costs Have Been Left Out Of Conversation

Lawmakers across the country and federally have been trying to figure out the best way to address surprise medical bills. But one of the main causes of the problem --ambulance rides -- isn't in any of the proposed legislation. “If you call 911 for an ambulance, it’s basically a coin flip whether or not that ambulance will be in or out of network," said Christopher Garmon, a health economist at...

Leafbuyer Technologies, Inc. Expands National Footprint

Signs Advertising Agreement with TheCHIVE Leafbuyer Technologies, Inc. (LBUY) (“Leafbuyer” or “the Company”) announced today its agreement with TheCHIVE, a culture, media, and entertainment outlet based in Austin, Texas. TheCHIVE was added to The Leafbuyer Total Network. Founded in 2008 by two entrepreneurs,

IMFINZI® (durvalumab) US Label Updated With Overall Survival Data in Unresectable, Stage III Non-small Cell Lung Cancer

IMFINZI is the only immunotherapy approved to treat patients in this curative-intent setting following chemoradiation therapy AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved the inclusion of overall survival (OS) data from the Phase III PACIFIC trial in an update to the IMFINZI® (durvalumab) US Prescribing Information for patients with unresectable, Stage...

Walgreens Launches WE Teachers Program to Support America’s Teachers with Free Tools and Resources to Address Critical Issues

Shop back to school at Walgreens to join the company’s commitment to supporting America’s teachers Nominate an exceptional teacher to receive a $500 WE Teachers Award toward classroom supplies New program helps teachers navigate discussions about bullying, mental health and wellbeing, youth violence and other critical social issues facing today’s students Teachers today are much mor...

Amneal Announces Launch of Generic Lyrica®

- Company has launched 21 generic products so far in 2019 - Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received approval for, and launched, its generic version of Lyrica® (pregabalin capsules) 25 mg, 50 mg, 75, mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg. The Company has now launched 21 generic products in 2019. “This new generic launch provides an important ...

Epizyme Strengthens Leadership Team with Appointment of Paolo Tombesi as Chief Financial Officer

Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced the appointment of Paolo Tombesi as chief financial officer, effective August 2019. Mr. Tombesi brings over 30 years of extensive financial and accounting expertise to Epizyme, most recently serving as the chief financial officer at Insmed, Incorporated. “We are delighte...

aap is granted European patent for its innovative resorbable magnesium implant technology

DGAP-News: aap Implantate AG / Key word(s): Patent 22.07.2019 / 10:14 The issuer is solely responsible for the content of this announcement. aap Implantate AG ("aap") announces that it was recently granted a further key European patent for its innovative magnesium implant technology. The patent (EP 2 593 152 B1) describes and protects the process by which aap's magnesium implants are co...

Broadspire Announces Prosthetic Partnership with HomeCare Connect

Broadspire, a Crawford Company, has chosen HomeCare Connect as its preferred partner for prosthetics and custom orthotics. The partnership will provide highly specialized care management services for injured workers who have undergone amputations. “We appreciate the specialized care and cost containment this partnership brings to our clients and the injured workers we advocate for,” said Er...

ENDRA Life Sciences to Host Second Quarter 2019 Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. ET

ANN ARBOR, MI / ACCESSWIRE / July 22, 2019 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, will hold a conference call on Thursday, August 8, 2019 at 4:30 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2019. Financial results will be issued in a press release prior to the call. ENDRA CEO Francois Michelon, C...

P1vital announces launch of the Reward Task Optimisation Consortium - RTOC

Research partners from pharma, academia, and SMEs have come together to form the Reward Task Optimisation Consortium (RTOC). Emerging from the ECNP Experimental Medicine Network and formally launched in April 2019, RTOC is a pre-competitive initiative aiming to advance the development of clinical tools to measure impaired motivation in people suffering from mental disorders. In clinical practic...

Tiziana Reports Phase 2a Clinical Data with Milciclib Monotherapy in Sorafenib-refractory or -intolerant patients with unresectable or metastatic Hepatocellular Carcinoma

Milciclib was well tolerated and no drug related deaths were reported 28 out of 31 treated patients were evaluable, with 14 patients completing the 6-month study duration 9 patients continued treatment under compassionate use, of which 5 are currently continuing with treatment     THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION...

Study Investigates the Ability of Continuous Noninvasive Hemoglobin Monitoring with Masimo SpHb® to Reflect Acute Hemodilution During Incremental Fluid Administration

Masimo (NASDAQ: MASI) announced today that in a study recently published in Anesthesia & Analgesia, researchers evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb® to detect the development of acute hemodilution after graded fluid administration, by comparing it to invasively measured laboratory hemoglobin (BHb), on patients undergoing major surgery.1


Quick Search

News Quicklinks